This article has been corrected to disclose a financial relationship between the author, Konstantinos Bonotis, and Recordati, a pharmaceutical company which manufactures cariprazine. Konstantinos Bonotis served as an advisory board member for Recordati in December, 2022. As a result, an honorarium was awarded to the University of Thessaly's Research Committee.